Financing, Equity Capital Markets

Marker Therapeutics, Inc.

03/21
|
$56.5 Million
Piper Sandler served as sole bookrunner for Marker Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma